Explore more publications!
Africa In The News
Got News to Share?

Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 1, 2026

Le Z Restaurant & Lounge Fait de la Ladies Night un Concept Unique à Kinshasa
May. 1, 2026

Le Z Restaurant & Lounge Fait de la Ladies Night un Concept Unique à Kinshasa

Indeterminate EIN Presswire
Newcore Gold Files Technical Report for the Updated Mineral Resource Estimate for the Enchi Gold Project, Ghana
17 hours ago

Newcore Gold Files Technical Report for the Updated Mineral Resource Estimate for the Enchi Gold Project, Ghana

Indeterminate GlobeNewswire
Atlas Civils Announces Major Expansion Plan and Donsa Phambili Social Impact Drive
May. 1, 2026

Atlas Civils Announces Major Expansion Plan and Donsa Phambili Social Impact Drive

Indeterminate EIN Presswire
Arctic Canadian Diamond Company Ltd. files for CCAA protection
May. 1, 2026

Arctic Canadian Diamond Company Ltd. files for CCAA protection

Indeterminate GlobeNewswire
Trident Resources Engages Marketing Groups and Announces the Recent Exercise of 1.38M Warrants for $1.87M in Cash
May. 1, 2026

Trident Resources Engages Marketing Groups and Announces the Recent Exercise of 1.38M Warrants for $1.87M in Cash

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
May. 1, 2026

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May. 1, 2026

Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Swift Seed Micro Launches Blockchain-Powered Micro-Financing Initiative for Emerging Markets
May. 1, 2026

Swift Seed Micro Launches Blockchain-Powered Micro-Financing Initiative for Emerging Markets

Indeterminate EIN Presswire
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
May. 1, 2026

Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

Indeterminate GlobeNewswire
Nasus Pharma to Participate in Upcoming Investor Conferences
May. 1, 2026

Nasus Pharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
GoldHaven Reports Independent Review Confirming Large-Scale Hydrothermal System and Identifies High-Priority Drill Targets at Copeçal
May. 1, 2026

GoldHaven Reports Independent Review Confirming Large-Scale Hydrothermal System and Identifies High-Priority Drill Targets at Copeçal

Indeterminate GlobeNewswire
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May. 1, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
May. 1, 2026

Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET

Indeterminate GlobeNewswire
InflaRx to Report First Quarter 2026 Results on May 7, 2026
May. 1, 2026

InflaRx to Report First Quarter 2026 Results on May 7, 2026

Indeterminate GlobeNewswire
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
May. 1, 2026

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity
May. 1, 2026

Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
Hudbay Announces First Quarter 2026 Results and Delivers Record Quarterly Revenue and Adjusted EBITDA
May. 1, 2026

Hudbay Announces First Quarter 2026 Results and Delivers Record Quarterly Revenue and Adjusted EBITDA

Indeterminate GlobeNewswire
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May. 1, 2026

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Indeterminate GlobeNewswire
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
May. 1, 2026

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions